Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02936128 · ClinicalTrials.gov registry record · Phase 4
TruSkin®: Study for Treatment of Chronic Venous Leg Ulcers
A Phase 4 study, sponsored by Osiris Therapeutics.
- Terminated
- Registry status
- Phase 4
- Development phase
- 7
- Enrollment target
NCT02936128 is a Phase 4 study that was terminated before completion, run by Osiris Therapeutics. The registered enrollment target is 7 participants.
The verdict
NCT02936128, a Phase 4 study, was terminated before completion, sponsored by Osiris Therapeutics.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 7 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the clinical outcomes of TruSkin® and an Active Comparator in patients with chronic venous leg ulcers.
Interventions
- OTHER Wound Cover
- OTHER TruSkin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2016-07 |
| Est. Completion | 2017-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02936128
The ClinicalTrials.gov registry entry for NCT02936128 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Osiris Therapeutics, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Wound Cover is the first listed.
NCT02936128 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02936128 about?
NCT02936128 is a clinical study titled "TruSkin®: Study for Treatment of Chronic Venous Leg Ulcers". The purpose of this study is to compare the clinical outcomes of TruSkin® and an Active Comparator in patients with chronic venous leg ulcers.
What is the current status of trial NCT02936128?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 7 participants. The study started on 2016-07. Estimated completion is 2017-04.
What interventions are being tested in trial NCT02936128?
The interventions under investigation include: Wound Cover (OTHER), TruSkin (OTHER).
Who is sponsoring clinical trial NCT02936128?
This trial is sponsored by Osiris Therapeutics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.